Midomafetamine/Citalopram Hydrochloride

亚甲二氧甲基苯丙胺/盐酸西酞普兰

Report date: 2024/10/29 14:39:49
NME

Base Information

Drug NameMidomafetamine/Citalopram Hydrochloride
Drug Alias NameMDMA+citalopram
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors agonistsCentral nervous system stimulantsSerotonin transporter inhibitors +[4] 
TargetsAdrenergic receptorsSerotonin transporterMonoamine transporters
Therapy Area/IndicationsStress Disorders, Post-Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes MidomafetamineCitalopram Hydrochloride
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTactogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesTactogen Inc
Inactive CompaniesN/A
Active IndicationsStress Disorders, Post-Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A